Biotechnology
Eli Lilly’s obesity pill will rival Novo Nordisk’s oral Wegovy drug
Eli Lilly’s Obesity Pill Orforglipron Challenges Novo Nordisk’s Oral Wegovy in Weight-Loss Market Race August 24, 2025 The obesity drug market, projected to surpass ...
Amgen to invest $600 million in new R&D facility in California
Biotechnology giant Amgen Inc. has announced a major investment exceeding $600 million to construct a state-of-the-art research and development (R&D) center at its global ...
Eli Lilly to build $5 billion Virginia manufacturing facility
Eli Lilly’s $5 Billion Bet on Virginia: A Game-Changer for U.S. Drug Manufacturing In a bold move to fortify America’s pharmaceutical backbone amid looming ...









